Shots:
Labcorp won Invitae’s auction bid, in the sale process under US Bankruptcy Code Section 363
Following the auction, LabCorp will acquire all assets for $239M in cash, plus other non-cash consideration
The current hearing date of sale approval is May 6, 2024. Deal closing is expected by Q3’24, with court approval, customary regulatory clearances and closing conditions
Ref: Labcorp | Image: Labcorp
Related News:- Labcorp Launched Neurofilament Light Chain Blood Test to Identify Neurodegenerative Disease
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
